Wolverine Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51M Sell
40,000
-3,800
-9% -$265K 0.02% 508
2025
Q4
$2.91M Hold
43,800
0.02% 483
2025
Q3
$2.95M Buy
43,800
+40,000
+1,053% +$3.17M 0.02% 471
2025
Q2
$332K Hold
3,800
﹤0.01% 953
2025
Q1
$260K Hold
3,800
﹤0.01% 977
2024
Q4
$296K Hold
3,800
﹤0.01% 958
2024
Q3
$255K Buy
+3,800
New +$312K ﹤0.01% 990
2021
Q1
Sell
-160,000
Closed -$14.8M 2075
2020
Q4
$14.8M Hold
160,000
0.11% 153
2020
Q3
$16.5M Hold
160,000
0.15% 120
2020
Q2
$16.2M Buy
+160,000
New +$14.3M 0.16% 126

Other funds holding DXCM

Wolverine Asset Management's DXCM Position: Q3 2025 in Review

Wolverine Asset Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 1,572 shares — an estimated $124K sold.

Wolverine Asset Management first reported a position in DXCM in Q2 2017 and held it in 6 quarters. The position peaked at $1.6M in Q4 2018. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Wolverine Asset Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 1,572 DexCom shares in Q3 2025, an estimated $124K.
  • Wolverine Asset Management first reported a position in DexCom in Q2 2017 and held it in 6 quarters.
  • Wolverine Asset Management's DexCom position peaked at $1.6M in Q4 2018.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.